Table 2.
Relationship between PSMC2 expression and tumor characteristics in patients with ovarian cancer.
| Features | No. of patients | PSMC2 expression | P value | |
|---|---|---|---|---|
| Low | High | |||
| All patients | 148 | 56 | 92 | |
| Age (years) | 0.197 | |||
| <52 | 74 | 32 | 42 | |
| ≥52 | 73 | 24 | 49 | |
| Grade | 0.019* | |||
| I | 14 | 6 | 8 | |
| II | 17 | 10 | 7 | |
| III | 86 | 23 | 63 | |
| T Infiltrate | 0.715 | |||
| T1 | 9 | 5 | 4 | |
| T2 | 35 | 12 | 23 | |
| T3 | 103 | 38 | 65 | |
| Lymphatic metastasis (N) | 0.897 | |||
| N0 | 106 | 40 | 66 | |
| N1 | 41 | 15 | 26 | |
| Metastasize (M) | 0.790 | |||
| M0 | 114 | 42 | 72 | |
| M1 | 33 | 13 | 20 | |
| Stage | 0.896 | |||
| 1 | 9 | 5 | 4 | |
| 2 | 35 | 12 | 23 | |
| 3 | 70 | 25 | 45 | |
| 4 | 33 | 13 | 20 | |
| Tumor size | 0.118 | |||
| <12.5 cm | 73 | 23 | 50 | |
| ≥12.5 cm | 75 | 33 | 42 | |
| Tumor recurrence | 0.359 | |||
| No | 29 | 13 | 16 | |
| Yes | 118 | 42 | 76 | |